Practice Areas - Equity Capital Markets Law Firms and Lawyers
| Deal Date: | 14-03-2012 | Practice Area: | Equity Capital Markets |
| Deal Title: | Amylin Pharmaceuticals Common Stock | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Davis Polk advised Credit Suisse Securities (USA) LLC as the sole underwriter in connection with an SEC-registered offering of 13,000,000 shares of common stock of Amylin Pharmaceuticals, Inc. for approximately $200 million.
Amylin Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to improving lives of patients through the discovery, development and commercialization of innovative medicines. The company is committed to delivering novel therapies that transform the way diabetes and other metabolic disorders are treated.
The Davis Polk corporate team included partner Bruce K. Dallas and associates Matthew Jones and Jacqueline M. Pace. Partner Rachel D. Kleinberg and New York associate Una Au provided tax advice. Associate Emma Maconick provided intellectual property advice. New York counsel Loyti Cheng provided environmental advice. Elizabeth J. Gordon and Nam Kim were the legal assistants on the transaction. Except as notes above, all members of the Davis Polk team are based in the Menlo Park office.
|
||
| Financial Center: | Silicon Valley | Value: | 100.01-500.00 |
| Advised Party: | Underwriter | Law Firm | Davis Polk |
| Issuer Jurisdiction - | United States | Listing Jurisdiction - | United States |
| Classification: |
Secondary Offerings and Placings NASDAQ: |
Lawyer | Bruce K Dallas |
